References
- Buysse DJ, Rush AJ, Reynolds CF. Clinical management of insomnia disorder. JAMA. 2017;318(20):1973. doi:10.1001/jama.2017.1568329059360
- Buysse DJ. Insomnia. JAMA. 2013;309(7):706. doi:10.1001/jama.2013.19323423416
- Li L, Wu C, Gan Y, et al. Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2016;16(1):375. doi:10.1186/s12888-016-1075-327816065
- Meng L, Zheng Y, Hui R. The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res. 2013;36(11):985–995. doi:10.1038/hr.2013.7024005775
- He Q, Zhang P, Li G, et al. The association between insomnia symptoms and risk of cardio-cerebral vascular events: a meta-analysis of prospective cohort studies. Eur J Prev Cardiol. 2017;24(10):1071–1082. doi:10.1177/204748731770204328359160
- Sullivan S. Update on emerging drugs for insomnia. Expert Opin Emerg Dr. 2012;17(3):295–298. doi:10.1517/14728214.2012.693158
- Singh A, Zhao K. Treatment of insomnia with traditional Chinese herbal medicine. Int Rev Neurobiol. 2017;135:97–115. doi:10.1016/bs.irn.2017.02.00628807167
- Li M, Wang J, He Q, et al. Compatibility law of Chinese patent medicine of treating insomnia recorded in Pharmacopeia of the People’s Republic of China. J Tradit Chin Med. 2016;57(7):558–562.
- Li Y, Bi K. Study on the therapeutic material basis of traditional Chinese medicinal preparation Suanzaoren decoction. Chem Pharm Bull. 2006;54(6):847–851. doi:10.1248/cpb.54.84716755056
- Tu Y, Cheng S, Sun H, et al. Ferulic acid potentiates pentobarbital-induced sleep via the serotonergic system. Neurosci Lett. 2012;525(2):95–99. doi:10.1016/j.neulet.2012.07.06822897877
- Zhou Q, Zhou X, Xu M, et al. Suanzaoren formulae for insomnia: updated clinical evidence and possible mechanisms. Front Pharmacol. 2018;9:76. doi:10.3389/fphar.2018.0007629479317
- Gao J, Wang Q, Huang Y, et al. In silico study of anti-insomnia mechanism for Suanzaoren prescription. Front Pharmacol. 2019;10:925. doi:10.3389/fphar.2019.0092531507421
- Zhao Z, Egashira Y, Sanada H. Digestion and absorption of ferulic acid sugar esters in rat gastrointestinal tract. J Agr Food Chem. 2003;51(18):5534–5539. doi:10.1021/jf034455u12926910
- Zhao Z, Egashira Y, Sanada H. Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver. J Nutr. 2004;134(11):3083–3088. doi:10.1093/jn/134.11.308315514279
- Zhao Z, Egashira Y, Sanada H. Ferulic acid sugar esters are recovered in rat plasma and urine mainly as the sulfoglucuronide of ferulic acid. J Nutr. 2003;133(5):1355–1361. doi:10.1093/jn/133.5.135512730422
- Adam A, Crespy V, Levrat-Verny M, et al. The bioavailability of ferulic acid is governed primarily by the food matrix rather than its metabolism in intestine and liver in rats. J Nutr. 2002;132(7):1962–1968. doi:10.1093/jn/132.7.196212097677
- Zhang C, Ma W, Zhang Y, et al. Pharmacokinetics, bioavailability, and tissue distribution study of angoroside C and its metabolite ferulic acid in rat using UPLC-MS/MS. Front Pharmacol. 2018;9:1186. doi:10.3389/fphar.2018.0118630405411
- Subbaiah M AM, Mandlekar S, Desikan S, et al. Design, synthesis, and pharmacokinetic evaluation of phosphate and amino acid ester prodrugs for improving the oral bioavailability of the HIV-1 protease inhibitor atazanavir. J Med Chem. 2019;62(7):3553–3574. doi:10.1021/acs.jmedchem.9b0000230938524
- Kesharwani SS, Ahmad R, Bakkari MA, et al. Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): formulation development, characterization and pharmacological evaluation. J Control Release. 2018;290:165–179. doi:10.1016/j.jconrel.2018.08.00430142410
- Kumar S, Kesharwani SS, Mathur H, et al. Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin. Eur J Pharm Sci. 2016;82:86–96. doi:10.1016/j.ejps.2015.11.01026588875
- Chen W, Miao YQ, Fan DJ, et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech. 2011;12(2):705–711. doi:10.1208/s12249-011-9632-z21637946
- Panwar R, Raghuwanshi N, Srivastava AK, et al. In-vivo sustained release of nanoencapsulated ferulic acid and its impact in induced diabetes. Mater Sci Eng C. 2018;92:381–392. doi:10.1016/j.msec.2018.06.055
- Zhang Y, Zhang K, Li Z, et al. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles. Int J Pharmaceut. 2016;511(1):57–64. doi:10.1016/j.ijpharm.2016.06.131
- Hassanzadeh P, Arbabi E, Atyabi F, et al. Ferulic acid-loaded nanostructured lipid carriers: a promising nanoformulation against the ischemic neural injuries. Life Sci. 2018;193:64–76. doi:10.1016/j.lfs.2017.11.04629196052
- Vashisth P, Sharma M, Nikhil K, et al. Antiproliferative activity of ferulic acid-encapsulated electrospun PLGA/PEO nanofibers against MCF-7 human breast carcinoma cells. 3 Biotech. 2015;5(3):303–315. doi:10.1007/s13205-014-0229-6
- Bala V, Rao S, Bateman E, et al. Enabling oral SN38-based chemotherapy with a combined lipophilic prodrug and self-microemulsifying drug delivery system. Mol Pharm. 2016;13(10):3518–3525. doi:10.1021/acs.molpharmaceut.6b0059127583840
- Ding W, Hou X, Cong S, et al. Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus. Drug Deliv. 2016;23(7):2513–2523. doi:10.3109/10717544.2015.102011925835221
- Lu YY, Wang XW, Wang X, et al. Profile of disposition, tissue distribution and excretion of the novel anti-human immunodeficiency virus (HIV) agent W-1 in rats. Arch Pharm Res. 2016;39(7):970–977. doi:10.1007/s12272-016-0727-727283844
- Chen L, Liu CS, Chen QZ, et al. Characterization, pharmacokinetics and tissue distribution of chlorogenic acid-loaded self-microemulsifying drug delivery system. Eur J Pharm Sci. 2017;100:102–108. doi:10.1016/j.ejps.2017.01.01128089660
- Wu Y, Ai Y, Wang F, et al. Determination of ferulic acid in rat plasma by UPLC-MS/MS and its application in a comparative pharmacokinetic. J Shenyang Pharm Univ. 2016;33(5):396–401.
- Rondini L, Peyrat-Maillard M, Marsset-Baglieri A, et al. Sulfated ferulic acid Is the main in vivo metabolite found after short-term ingestion of free ferulic acid in rats. J Agr Food Chem. 2002;50(10):3037–3041. doi:10.1021/jf011295i11982438
- Kokumai T, Ito J, Kobayashi E, et al. Comparison of blood profiles of γ-oryzanol and ferulic acid in rats after oral intake of γ-oryzanol. Nutrients. 2019;11(5):1174. doi:10.3390/nu11051174
- Wang G, Wang J, Li F, To ST. Development and evaluation of a novel drug delivery: pluronics/SDS mixed micelle loaded with myricetin in vitro and in vivo. J Pharm Sci-Us. 2016;105(4):1535–1543. doi:10.1016/j.xphs.2016.01.016
- Kaur P, Kim K. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits. Int J Pharmaceut. 2008;364(1):27–35. doi:10.1016/j.ijpharm.2008.07.030